37 results
6-K
EX-99.1
BPTS
Biophytis
19 Apr 22
Current report (foreign)
9:51am
authorizations and procedures, any delays in patient recruitment or retention, interruptions in sourcing or supply chain, and to COVID-19-related delays
6-K
EX-99.1
BPTS
Biophytis
7 Apr 22
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives
11:09am
recruitment or retention, interruptions in sourcing or supply chain, and to COVID-19-related delays.
For the MYODA study in Duchenne Muscular Dystrophy (DMD
20-F/A
j2k o34m5mnvcapw4mkx
28 Oct 21
Annual report (foreign) (amended)
5:16pm
6-K
EX-99.1
68n5rqdts
8 Jul 21
Biophytis Reinforces Leadership Teams with Three Senior Appointments
6:04am
6-K
EX-99.1
uv3e npnp5nu
1 Jul 21
Current report (foreign)
6:31am
6-K
EX-99.1
xhw1pn9g5gzu07qyb
1 Jul 21
Results of Biophytis SARA-INT Phase 2 Trial with Sarconeos (BIO101) in Sarcopenia will be Released by August 2021
6:29am
6-K
EX-99.1
xyigbt 83q
22 Jun 21
Current report (foreign)
8:19am
6-K
EX-99.1
9u3o1lsnf2btubg
12 May 21
Biophytis Completed Recruitment of 155 Participants to the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19
7:48am
6-K
EX-99.1
40k076x4in4 60iyonn
11 May 21
Current report (foreign)
8:48am
6-K
EX-99.1
wn653 njq
30 Apr 21
Current report (foreign)
6:12am
6-K
EX-99.1
ptd p9tzuywiizdaprlh
29 Apr 21
Biophytis Receives €980,000 DeepTech Funding from BPI France for the development of Macuneos (BIO201) in dry AMD
7:02am
6-K
EX-99.1
vqprk6e jiq
28 Apr 21
Current report (foreign)
9:31am
6-K
EX-99.1
ks6kpbb u3j5ig0f8hg
28 Apr 21
Biophytis - Convening of Another Combined General Meeting at a Later Date
6:01am
20-F
co61 1n92692
12 Mar 21
Annual report (foreign)
2:38pm
6-K
EX-99.1
3x3vngo
26 Feb 21
Biophytis Reports 2020 Full Year Results
4:06pm
6-K
EX-99.1
iwr2ef
17 Feb 21
Current report (foreign)
9:32am
424B4
ghhw5
11 Feb 21
Prospectus supplement with pricing info
12:00am